Positives

• Dapagliflozin may be of interest when Long COVID overlaps with diabetes, insulin resistance, heart failure risk, kidney concerns, or metabolic inflammation (PubMed).
• Some patients and clinicians think about SGLT2 medications when blood-sugar instability, fluid balance, or cardiometabolic strain appears to be part of the illness picture (Drugs.com).

Negatives

• It is not established as a treatment for Long COVID, ME/CFS, Lyme, POTS, MCAS, or post-viral fatigue itself (Lancet Diabetes & Endocrinology).
• Because it increases glucose and fluid loss through urine, it may worsen dehydration, dizziness, or orthostatic symptoms in some dysautonomia patients (PMC).

Hurdles & Side Effects

• Patient reviews include severe dehydration, diarrhea, and genital/urinary issues, which can be especially relevant for medication-sensitive patients (Drugs.com).
• Patients with POTS, low blood pressure, poor oral intake, or recurrent infections would need careful clinician guidance (PMC).